Pneumonia Market Therapeutics Review H2 2025
Synopsis
Pneumonia is a lung infection that causes inflammatory
condition in one or both lungs. It affects small air sacs known as alveoli by
filing them with fluid or pus, making a person difficult to breathe. It can be
classified into community-acquired pneumonia and hospital-acquired pneumonia.
Hospital acquired pneumonia can be further classified into healthcare
associated pneumonia and ventilator associated pneumonia. A person suffering
from pneumonia can experience problems like fever along with chills, cough with
pus or phlegm, shortness of breath, pain in chest while breath in or coughing
and lower than normal body temperature, rapid heartbeats, ongoing nausea or
vomiting and decline in energy levels.
The U.S. is expected to be the first region to start selling
pneumonia drugs in pipeline and later on, penetration of pneumonia drugs would
occur in Europe. The U.S. and Europe have high prevalence of severe forms of
multiple drug resistance (MDR) organism which would result into a high demand
for pneumonia drugs in future.
Click here for
sample report @http://www.wiseguyreports.com/sample-request/2855878-global-pneumonia-market-industry-analysis-outlook-2018-2025
Key Highlights
The global pneumonia market is expected to grow in future
with growing ageing population, increasing pharmaceutical R&D spending,
increasing healthcare expenditure, accelerating economic growth, growing
children population and rise in multiple drug resistance (MDR) organisms. Key
trends of this market include progressing drug under pipeline, innovation in
treatment options and increased preference towards combination therapy.
However, there are some factors which can hinder growth of the market including
stringent regulations and entry of generic drugs.
The report “Global Pneumonia Market: Industry Analysis &
Outlook (2018-2025)” by Koncept Analytics provides an extensive research and
detailed analysis of the present market along with future outlook. The report
discusses the major growth drivers and challenges of the market, covering U.S,
and Europe along with the global market. The report profiles key players of the
market including Merck & Co. Inc., Allergan Plc, The Medicines Company and
Nabriva Therapeutics.
Table of Content
1. Market Overview
1.1 Pneumonia
1.2 Causes
1.3 Symptoms and Diagnosis
1.4 Treatment
1.2 Causes
1.3 Symptoms and Diagnosis
1.4 Treatment
2. Global Pneumonia Market Analysis
2.1 Pneumonia Market
2.1.1 Global Lefamulin Drug Revenue Forecast
2.1.2 Global ASN100 Drug Revenue Forecast
2.1.1 Global Lefamulin Drug Revenue Forecast
2.1.2 Global ASN100 Drug Revenue Forecast
3. Regional Markets
3.1 The U.S.
3.1.1 The U.S. CAP Patient Population Forecast
3.1.2 The U.S. CAP Patient Population by Category
3.1.3 The U.S. CAP Outpatient Population Forecast
3.1.4 The U.S. CAP Hospital Patient Population Forecast
3.1.5 The U.S. HAP/VAP Population Forecast
3.1.6 The U.S. Lefamulin Drug Revenue Forecast by Category
3.1.7 The U.S. Lefamulin Drug Revenue Forecast by Patient Type for CAP
3.1.8 The U.S. Lefamulin Drug Revenue Forecast for HAP/VAP
3.1.9 The U.S. ASN100 Drug Revenue Forecast for VAP
3.1.1 The U.S. CAP Patient Population Forecast
3.1.2 The U.S. CAP Patient Population by Category
3.1.3 The U.S. CAP Outpatient Population Forecast
3.1.4 The U.S. CAP Hospital Patient Population Forecast
3.1.5 The U.S. HAP/VAP Population Forecast
3.1.6 The U.S. Lefamulin Drug Revenue Forecast by Category
3.1.7 The U.S. Lefamulin Drug Revenue Forecast by Patient Type for CAP
3.1.8 The U.S. Lefamulin Drug Revenue Forecast for HAP/VAP
3.1.9 The U.S. ASN100 Drug Revenue Forecast for VAP
3.2 Europe
3.2.1 Europe CAP Patient Population Forecast
3.2.2 Europe CAP Patient Population by Category
3.2.3 Europe CAP Hospital Patient Population by Category
3.2.4 Europe CAP Outpatient Population Forecast
3.2.5 Europe VAP Patient Population Forecast
3.2.6 Europe Lefamulin Drug Revenue Forecast by Patient Type for CAP
3.2.7 Europe ASN100 Drug Revenue Forecast for VAP
3.2.1 Europe CAP Patient Population Forecast
3.2.2 Europe CAP Patient Population by Category
3.2.3 Europe CAP Hospital Patient Population by Category
3.2.4 Europe CAP Outpatient Population Forecast
3.2.5 Europe VAP Patient Population Forecast
3.2.6 Europe Lefamulin Drug Revenue Forecast by Patient Type for CAP
3.2.7 Europe ASN100 Drug Revenue Forecast for VAP
For Detailed Reading Please visit @https://www.wiseguyreports.com/reports/2855878-global-pneumonia-market-industry-analysis-outlook-2018-2025
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
Comments
Post a Comment